StreetInsider.com News Articles

Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders

Wed, 24 Jun 2026 08:30:00 -0400

MINNEAPOLIS, June 24, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, reviews the year-to-date and outlines strategic priorities in a Letter to Shareholders from newly appointed CEO, Mike McCormick.

Dear Valued Shareholders,

Recently we announced an important leadership transition for Nuwellis. Effective June 30, 2026, I will assume the role of Chief Executive Officer, while John Erb will transition from his executive responsibilities and continue as Chairman of the Board.

We embark on this leadership transition with growing commercial momentum, improving margins,

Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders

Wed, 24 Jun 2026 08:30:00 -0400

Dear Valued Shareholders,

We embark on this leadership transition with growing commercial momentum, improving margins,

Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders

Wed, 24 Jun 2026 08:30:00 -0400

Dear Valued Shareholders,

We embark on this leadership transition with growing commercial momentum, improving margins,

Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders

Wed, 24 Jun 2026 08:30:00 -0400

Dear Valued Shareholders,

We embark on this leadership transition with growing commercial momentum, improving margins,

Form 8-K Nuwellis, Inc. For: Jun 23

Wed, 24 Jun 2026 06:00:00 -0400

si-local-file:///var/storage/secattach/20260624/26681614.html

Form 8-K Nuwellis, Inc. For: Jun 23

Wed, 24 Jun 2026 06:00:00 -0400

si-local-file:///var/storage/secattach/20260624/26681614.html

Nuwellis trains 280+ physicians on Aquadex at Minnesota summit

Thu, 18 Jun 2026 08:30:54 -0400

Nuwellis, Inc. (Nasdaq: NUWE) conducted hands-on training sessions for its Aquadex SmartFlow system at the 4th annual Critical Care Cardiology Education Summit (CCCES), hosted by the University of Minnesota.

More than 280 physicians completed hands-on Aquadex training during the event. The summit brought together cardiology fellows, attending physicians, intensivists, and critical care specialists from across the country.

This year's conference theme focused on the management of bleeding and coagulopathy in critically ill cardiac patients, featuring lectures, case-based discussions, and hands-on procedural training.

"CCCES is uniquely designed to provide experiential learning and hands-on skills training for clinicians managing some of the most complex patients

Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit